Log in

NASDAQ:PAVMPAVmed Stock Price, Forecast & News

$2.02
-0.01 (-0.49 %)
(As of 07/14/2020 04:00 PM ET)
Add
Compare
Today's Range
$2.01
Now: $2.02
$2.18
50-Day Range
$1.94
MA: $2.13
$2.44
52-Week Range
$0.81
Now: $2.02
$3.45
Volume915,100 shs
Average Volume1.16 million shs
Market Capitalization$95.88 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.01
PAVmed Inc. operates as a medical device company in the United States. The company's lead product pipeline includes CarpX, a percutaneous device to treat carpal tunnel syndrome; EsoCheck, an non-invasive cell collection device and DNA biomarkers to detect esophageal cancer precursor; PortIO, an implantable intraosseous vascular access device; and DisappEAR, an antimicrobial resorbable ear tube. Its product pipeline also comprises NextCath, a self-anchoring catheter; NextFlo, a disposable infusion system; and Caldus, a disposable tissue ablation device. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was founded in 2014 and is based in New York, New York.
Read More
PAVmed logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.22 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PAVM
CUSIPN/A
Phone212-949-4319

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value($0.18) per share

Profitability

Net Income$-16,460,000.00

Miscellaneous

Employees9
Market Cap$95.88 million
Next Earnings Date8/12/2020 (Estimated)
OptionableNot Optionable

Receive PAVM News and Ratings via Email

Sign-up to receive the latest news and ratings for PAVM and its competitors with MarketBeat's FREE daily newsletter.

PAVmed (NASDAQ:PAVM) Frequently Asked Questions

How has PAVmed's stock been impacted by COVID-19 (Coronavirus)?

PAVmed's stock was trading at $1.74 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, PAVM stock has increased by 16.1% and is now trading at $2.02. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of PAVmed?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PAVmed in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for PAVmed.

When is PAVmed's next earnings date?

PAVmed is scheduled to release its next quarterly earnings announcement on Wednesday, August 12th 2020. View our earnings forecast for PAVmed.

How were PAVmed's earnings last quarter?

PAVmed Inc (NASDAQ:PAVM) posted its quarterly earnings data on Thursday, May, 21st. The company reported ($0.10) earnings per share (EPS) for the quarter. View PAVmed's earnings history.

What price target have analysts set for PAVM?

1 analysts have issued 12 month target prices for PAVmed's shares. Their forecasts range from $5.00 to $5.00. On average, they expect PAVmed's share price to reach $5.00 in the next year. This suggests a possible upside of 147.5% from the stock's current price. View analysts' price targets for PAVmed.

Has PAVmed been receiving favorable news coverage?

Media stories about PAVM stock have been trending positive this week, according to InfoTrie Sentiment. The research group identifies positive and negative media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. PAVmed earned a news sentiment score of 2.5 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near term. View the latest news about PAVmed.

Who are some of PAVmed's key competitors?

What other stocks do shareholders of PAVmed own?

Who are PAVmed's key executives?

PAVmed's management team includes the following people:
  • Dr. Lishan Aklog M.D., Chairman & CEO (Age 53)
  • Mr. Dennis M. McGrath CPA, Pres, CFO & Sec. (Age 62)
  • Dr. Brian J. deGuzman M.D., Chief Medical Officer (Age 54)
  • Mike Havrilla, Director of Investor Relations
  • Mr. Shaun M. O'Neil, Chief Commercial Officer

What is PAVmed's stock symbol?

PAVmed trades on the NASDAQ under the ticker symbol "PAVM."

How do I buy shares of PAVmed?

Shares of PAVM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is PAVmed's stock price today?

One share of PAVM stock can currently be purchased for approximately $2.02.

How big of a company is PAVmed?

PAVmed has a market capitalization of $95.88 million. PAVmed employs 9 workers across the globe.

What is PAVmed's official website?

The official website for PAVmed is www.pavmed.com.

How can I contact PAVmed?

PAVmed's mailing address is ONE GRAND CENTRAL PLACE SUITE 4600, NEW YORK NY, 10165. The company can be reached via phone at 212-949-4319 or via email at [email protected]

This page was last updated on 7/15/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.